Clinical Case Reports (Nov 2021)

Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy

  • David Bobrowski,
  • Reha Kumar,
  • Peter E. Wu,
  • Lauren Lapointe‐Shaw

DOI
https://doi.org/10.1002/ccr3.5057
Journal volume & issue
Vol. 9, no. 11
pp. n/a – n/a

Abstract

Read online

Abstract Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations.

Keywords